Not logged in Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia Share Save
Share Save
Share Save
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy De Lucia, Anna; Mazzotti, Lucia; Gaimari, Anna; Zurlo, Matteo; Maltoni, Roberta; Cerchione, Claudio; Bravaccini, Sara; Delmonte, Angelo; Crino, Lucio; de Souza, Patricia Borges; Pasini, Luigi; Nicolini, Fabio; Bianchi, Fabrizio; Juan, Manel; Calderon, Hugo; Magnoni, Chiara; Gazzola, Luca; Ulivi, Paola; Mazza, Massimiliano Share Save
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival Canale, Matteo; Urbini, Milena; Petracci, Elisabetta; Angeli, Davide; Tedaldi, Gianluca; Priano, Ilaria; Cravero, Paola; Flospergher, Michele; Andrikou, Kalliopi; Bennati, Chiara; Tassinari, Davide; Dubini, Alessandra; Rossi, Giulio; Panzacchi, Riccardo; Valli, Mirca; Bronte, Giuseppe; Crino, Lucio; Delmonte, Angelo; Ulivi, Paola Share Save
Share Save
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database Reale, M. L.; Passiglia, F.; Cappuzzo, F.; Minuti, G.; Occhipinti, M.; Bulotta, A.; Delmonte, A.; Sini, C.; Galetta, D.; Roca, E.; Pelizzari, G.; Cortinovis, D.; Gariazzo, E.; Pilotto, S.; Citarella, F.; Bria, E.; Muscolino, P.; Pozzessere, D.; Carta, A.; Pignataro, D.; Calvetti, L.; Leone, F.; Banini, M.; Di Micco, C.; Baldini, E.; Favaretto, A.; Malapelle, U.; Novello, S.; Pasello, G.; Tiseo, M. Share Save
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study Petracci, Elisabetta; Pasini, Luigi; Urbini, Milena; Felip, Enriqueta; Stella, Franco; Davoli, Fabio; Salvi, Maurizio; Beau-Faller, Michele; Tebaldi, Michela; Azzali, Irene; Canale, Matteo; Solli, Piergiorgio; Lai, Giulia; Amat, Ramon; Carbonell, Caterina; Falcoz, Pierre-Emmanuel; Martinez-Marti, Alex; Pencreach, Erwan; Delmonte, Angelo; Crino, Lucio; Ulivi, Paola Share Save
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) Citarella, Fabrizio; Takada, Kazuki; Cascetta, Priscilla; Crucitti, Pierfilippo; Petti, Roberta; Vincenzi, Bruno; Tonini, Giuseppe; Venanzi, Francesco M.; Bulotta, Alessandra; Oresti, Sara; Greco, Carlo; Ramella, Sara; Crino, Lucio; Delmonte, Angelo; Ferrara, Roberto; Di Maio, Massimo; Gurrieri, Fiorella; Cortellini, Alessio Share Save
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience Andrikou, Kalliopi; Ulivi, Paola; Petracci, Elisabetta; Azzali, Irene; Bertolini, Federica; Alberti, Giulia; Bettelli, Stefania; Calistri, Daniele; Chiadini, Elisa; Capelli, Laura; Cravero, Paola; Guaitoli, Giorgia; Zanelli, Francesca; Burgio, Marco Angelo; Pagano, Maria; Verlicchi, Alberto; Martinelli, Enrica; Di Emidio, Katia; Dominici, Massimo; Pinto, Carmine; Delmonte, Angelo Share Save
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL) Cafaro, Alessandro; Foca, Flavia; Nanni, Oriana; Chiumente, Marco; Coppola, Marina; Baldo, Paolo; Orzetti, Sabrina; Enrico, Fiorenza; Ladisa, Vito; Lerose, Rosa; Nardulli, Patrizia; Maiolino, Piera; Gradellini, Federica; Gasbarro, Anna Rita; Carrucciu, Gisella; Provasi, Riccardo; Cappelletto, Paola Cristina; Pasqualini, Alessandra; Vecchia, Stefano; Veraldi, Marianna; De Francesco, Adele Emanuela; Crino, Lucio; Delmonte, Angelo; Masini, Carla Share Save
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream Calabro, Luana; Bronte, Giuseppe; Grosso, Federica; Cerbone, Luigi; Delmonte, Angelo; Nicolini, Fabio; Mazza, Massimiliano; Di Giacomo, Anna Maria; Covre, Alessia; Lofiego, Maria Fortunata; Crino, Lucio; Maio, Michele Share Save
Durvalumab (durva) after sequential chemoradiotherapy (CRT) in patients (pts) with unresectable stage III NSCLC: Final analysis from PACIFIC-6 Garassino, M. C.; Mazieres, J.; Reck, M.; Chouaid, C.; Bischoff, H.; Reinmuth, N.; Cove-Smith, L. S.; Mansy, T.; Cortinovis, D. L.; Migliorino, M. R.; Delmonte, A.; Sanchez, J. Garcia; Velarde, L. E. Chara; Caro, R. Bernabe; Paz-Ares, L.; Chander, P.; Perez, I. Diaz; Foroutanpour, K.; Faivre-Finn, C. Share Save
Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study Filippi, A. R. R.; Garcia-Campelo, M. R.; Paoli, J. B.; Kowalski, D.; Bennati, C.; Borghetti, P.; Cortinovis, D. L.; Delmonte, A.; Genova, C.; Van Hulst, S.; Mroz, R.; Nawrocki, S.; Toledano, I.; Tonini, G.; Perez, I. Diaz; Georgoulia, N. E.; Foroutanpour, K.; Dziadziuszko, R. Share Save
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 Besse, B.; Felip, E.; Campelo, R. Garcia; Cobo, M.; Mascaux, C.; Madroszyk, A.; Cappuzzo, F.; Hilgers, W.; Romano, G.; Denis, F.; Viteri, S.; Debieuvre, D.; Galetta, D.; Baldini, E.; Razaq, M.; Robinet, G.; Maio, M.; Delmonte, A.; Roch, B.; Masson, P.; Schuette, W.; Zer, A.; Remon, J.; Costantini, D.; Vasseur, B.; Dziadziuszko, R. Share Save
Comprehensive molecular profiling of small cell lung cancer patients treated with chemo-immunotherapy or chemotherapy alone Urbini, M.; Canale, M.; Flospergher, M.; Andrikou, K.; Cravero, P.; Pasini, L.; Dubini, A.; Panzacchi, R.; Bennati, C.; Rossi, G.; Tassinari, D.; Valli, M.; Delmonte, A.; Crino, L.; Ulivi, P. Share Save
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer Verlicchi, Alberto; Canale, Matteo; Chiadini, Elisa; Cravero, Paola; Urbini, Milena; Andrikou, Kalliopi; Pasini, Luigi; Flospergher, Michele; Burgio, Marco Angelo; Crino, Lucio; Ulivi, Paola; Delmonte, Angelo Share Save
Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with KRAS G12C mutation Desai, Jayesh; Han, Sae-Won; Lee, Jong-Seok; Shacham-Shmueli, Einat; Massarelli, Erminia; Cervantes, Andres; Garralda, Elena; Falcon, Alejandro; Miller, Wilson H.; Gort, Eelke; Karasic, Thomas; Siena, Salvatore; Stec, Rafal; Medina, Laura; Paz-Arez, Luis; Delmonte, Angelo; Sacher, Adrian; Prenen, Hans; Forster, Martin; Kim, Tae Won; Krebs, Matthew G.; Cosman, Rasha; Choi, Yoonha; Mandlekar, Sandhya; Lin, Mark T.; Yau, Kenneth K.; Chang, Julie; Royer-Joo, Stephanie; Dharia, Neekesh V.; Schutzman, Jennifer L.; Patel, Manish Share Save
Combi-TED: a new trial testing Tedopi® with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line Landi, Lorenza; Delmonte, Angelo; Bonetti, Andrea; Pasello, Giulia; Metro, Giulio; Mazzoni, Francesca; Borra, Gloria; Giannarelli, Diana; Andrikou, Kalliopi; Mangiola, Daniela; Gori, Stefania; D'Andrea, Mario Rosario; Minuti, Gabriele; Resuli, Blerina; Laudisi, Anastasia; Vidiri, Antonello; Conti, Laura; Cappuzzo, Federico Share Save